search
Back to results

Post-Operative Imaging After Urethroplasty With Peri-catheter Retrograde Urethrography Or Trial of Voiding With Voiding Cysto-urethrography (POIROT)

Primary Purpose

Urethral Stricture

Status
Completed
Phase
Phase 2
Locations
Belgium
Study Type
Interventional
Intervention
Post-urethroplasty urethrography
Sponsored by
University Hospital, Ghent
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Urethral Stricture

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations (Appendix B).
  • Age ≥ 18 years.
  • Male patient.
  • Anterior urethral stricture disease (penile, bulbar, penobulbar and panurethral strictures are allowed).
  • Procedure was ended with leaving a transurethral catheter in place with foreseen catheter removal and early postoperative imaging after x days.

Exclusion Criteria:

  • Absence of signed written informed consent (Appendix B).
  • Age < 18 years.
  • Female patients.
  • Transgender patients.
  • Posterior urethral stenosis
  • Bladder neck reconstruction
  • Patients in which no catheter has been left in place at the end of the procedure.
  • Patients in which there is no need for early postoperative imaging, upon discretion of the treating clinician.

Sites / Locations

  • Dept. of Urology, Ghent University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

pcRUG

VCUG

Arm Description

Peri-catheter retrograde urethrography

Voiding cysto-urethrography

Outcomes

Primary Outcome Measures

Percentage of 'rightful decision to maintain the catheter at the time of imaging' between pcRUG only and VCUG.
In other words, the amount of catheters maintained during the investigation divided by the number of significant extravasations requiring perpetuated catheter stay.

Secondary Outcome Measures

Difference in radiation exposure between pcRUG and VCUG expressed in mGy/(cm*cm)
Difference in dose of radiation exposure will be assessed with the Mann-Whitney U-test.
Difference in the amount of significant extravasations that is picked up with pcRUG versus VCUG.
Results of both pcRUG and VCUG will be shown to the treating clinician at least 4 weeks after the original investigation and the clinician will have to choose between 'no or insignificant contrast leakage' versus 'significant contrast leakage'.
Intra-observer variability of both pcRUG and VCUG
Reproducibility will be assessed with intraclass correlation coefficients. A threshold of >0.70 will be used as threshold for good intraclass correlation and thus good reproducibility.
Inter-observer variability of both pcRUG and VCUG
Inter-observer variability will be assessed with Cohen's kappa. A threshold of >0.70 will be used for good inter-observer variability
Amount of patients unable to void while being on the X-ray table
During VCUG, patients have to void after catheter removal to allow urethral imaging. Often, patients are unable to void while on the X-ray table.

Full Information

First Posted
March 4, 2020
Last Updated
January 1, 2023
Sponsor
University Hospital, Ghent
search

1. Study Identification

Unique Protocol Identification Number
NCT04307537
Brief Title
Post-Operative Imaging After Urethroplasty With Peri-catheter Retrograde Urethrography Or Trial of Voiding With Voiding Cysto-urethrography
Acronym
POIROT
Official Title
POIROT TRIAL: Post-Operative Imaging After Urethroplasty With Peri-catheter Retrograde Urethrography Or Trial of Voiding With Voiding Cysto-urethrography
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Completed
Study Start Date
January 21, 2020 (Actual)
Primary Completion Date
September 1, 2021 (Actual)
Study Completion Date
September 1, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Ghent

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
After a reconstructive procedure of the urethra, a transurethral catheter is usually left in place to allow adequate healing of the tissues without exposure to urine. After 7-21 days, depending on several variables (e.g. type of reconstruction, stricture etiology, …), removal of the transurethral catheter is foreseen. However, in order to do so, the clinician first wants to objectify whether the urethra has indeed healed sufficiently and therefore he/she can rely on early postoperative imaging. Up until today, there is no clear standard about when and how to do early postoperative imaging and current practices are mainly based on expert opinion and habit. Basically, two strategies can be found amongst different urethroplasty centers: peri-catheter retrograde urethrography (pcRUG) and voiding cysto-urethrography (VCUG). A pcRUG is performed by placing a small caliber tube (e.g. feeding tube 5 Fr) in the meatus urethrae of the patient, next to the transurethral catheter (which remains in place), and injecting contrast alongside the catheter. With a VCUG, contrast is injected through the transurethral catheter, up to the bladder. Thereafter, the catheter is removed and the patient is asked to urinate and thus to pass contrast through the urethra. The primary end-point of this study is to compare 'the rightful decision to maintain the catheter at the time of imaging' between pcRUG only and pcRUG followed by VCUG in a within-patient fashion.
Detailed Description
After a reconstructive procedure of the urethra, a transurethral catheter is usually left in place to allow adequate healing of the tissues without exposure to urine. After 7-21 days, depending on several variables (e.g. type of reconstruction, stricture etiology, …), removal of the transurethral catheter is foreseen. However, in order to do so, the clinician first wants to objectify whether the urethra has indeed healed sufficiently and therefore he/she can rely on early postoperative imaging. Up until today, there is no clear standard about when and how to do early postoperative imaging and current practices are mainly based on expert opinion and habit. Basically, two strategies can be found amongst different urethroplasty centers: peri-catheter retrograde urethrography (pcRUG) and voiding cysto-urethrography (VCUG). A pcRUG is performed by placing a small caliber tube (e.g. feeding tube 5 Fr) in the meatus urethrae of the patient, next to the transurethral catheter (which remains in place), and injecting contrast alongside the catheter. With a VCUG, contrast is injected through the transurethral catheter, up to the bladder. Thereafter, the catheter is removed and the patient is asked to urinate and thus to pass contrast through the urethra. In both of the aforementioned imaging modalities, patients are installed similarly on the X-ray table and an antero-posterior X-ray image is made1. In patients with no or insignificant, wisp-like extravasation of contrast, the transurethral catheter can safely be removed. In case of significant contrast extravasation, as defined by Grossgold et al., the catheter is maintained or replaced for another week and one week later, imaging is repeated2. Both pcRUG and VCUG are not perfect and involve a number of flaws. The main issue with pcRUG is represented by the potential impact of several variables on the image: different levels of pressure in the urethra by different strength of injection, different calibers of tubes through which the contrast is injected, etc. As regards VCUG, an important amount of patients does not achieve to void while being on the X-ray table, which can lead to a long duration of the procedure or even no imaging at all. Another important problem is the fact that if the patient has a significant extravasation of contrast, the catheter needs to be replaced through the freshly reconstructed, and apparently still leaking, urethra. This may be difficult and is often bothersome for the patient. Given the drawbacks mentioned above, a combination of both techniques can be administered to overcome the flaws of each separate imaging modality and could as such be considered the standard of care in early postoperative imaging after urethroplasty. However, the combination of both techniques includes a higher exposure to radiation than one separate technique and one could wonder what the added value of VCUG after pcRUG is and whether or not this is worth the extra exposure to radiation. To date, there is no such data and a wide variability of strategies is used in the different urethroplasty practices worldwide. Against this background, the primary end-point of this study is to compare 'the rightful decision to maintain the catheter at the time of imaging' between pcRUG only and pcRUG followed by VCUG in a within-patient fashion.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urethral Stricture

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Phase 2
Interventional Study Model
Single Group Assignment
Model Description
Within patient comparison
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
80 (Actual)

8. Arms, Groups, and Interventions

Arm Title
pcRUG
Arm Type
Experimental
Arm Description
Peri-catheter retrograde urethrography
Arm Title
VCUG
Arm Type
Active Comparator
Arm Description
Voiding cysto-urethrography
Intervention Type
Procedure
Intervention Name(s)
Post-urethroplasty urethrography
Intervention Description
Imaging of the urethra after reconstructive surgery to identify contrast leakage (no, insignificant, signficant).
Primary Outcome Measure Information:
Title
Percentage of 'rightful decision to maintain the catheter at the time of imaging' between pcRUG only and VCUG.
Description
In other words, the amount of catheters maintained during the investigation divided by the number of significant extravasations requiring perpetuated catheter stay.
Time Frame
1 day (day of original investigation)
Secondary Outcome Measure Information:
Title
Difference in radiation exposure between pcRUG and VCUG expressed in mGy/(cm*cm)
Description
Difference in dose of radiation exposure will be assessed with the Mann-Whitney U-test.
Time Frame
1 day (moment of original investigation)
Title
Difference in the amount of significant extravasations that is picked up with pcRUG versus VCUG.
Description
Results of both pcRUG and VCUG will be shown to the treating clinician at least 4 weeks after the original investigation and the clinician will have to choose between 'no or insignificant contrast leakage' versus 'significant contrast leakage'.
Time Frame
Results of both pcRUG and VCUG will be shown to the treating clinician at least 4 weeks after the original investigation and the clinician will have to choose between 'no or insignificant contrast leakage' versus 'significant contrast leakage'.
Title
Intra-observer variability of both pcRUG and VCUG
Description
Reproducibility will be assessed with intraclass correlation coefficients. A threshold of >0.70 will be used as threshold for good intraclass correlation and thus good reproducibility.
Time Frame
First blinded assessment (at least 4 weeks after original investigation) versus second blinded assessment another 4 weeks later.
Title
Inter-observer variability of both pcRUG and VCUG
Description
Inter-observer variability will be assessed with Cohen's kappa. A threshold of >0.70 will be used for good inter-observer variability
Time Frame
Two experienced clinicians will be compared regarding decision making during the first blinded assessment (at least 4 weeks after the original investigation).
Title
Amount of patients unable to void while being on the X-ray table
Description
During VCUG, patients have to void after catheter removal to allow urethral imaging. Often, patients are unable to void while on the X-ray table.
Time Frame
1 day (moment of original investigation)

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations (Appendix B). Age ≥ 18 years. Male patient. Anterior urethral stricture disease (penile, bulbar, penobulbar and panurethral strictures are allowed). Procedure was ended with leaving a transurethral catheter in place with foreseen catheter removal and early postoperative imaging after x days. Exclusion Criteria: Absence of signed written informed consent (Appendix B). Age < 18 years. Female patients. Transgender patients. Posterior urethral stenosis Bladder neck reconstruction Patients in which no catheter has been left in place at the end of the procedure. Patients in which there is no need for early postoperative imaging, upon discretion of the treating clinician.
Facility Information:
Facility Name
Dept. of Urology, Ghent University Hospital
City
Ghent
State/Province
East-Flanders
ZIP/Postal Code
9000
Country
Belgium

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Post-Operative Imaging After Urethroplasty With Peri-catheter Retrograde Urethrography Or Trial of Voiding With Voiding Cysto-urethrography

We'll reach out to this number within 24 hrs